Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells

BRCA mutation, one of the most common types of mutations in breast and ovarian cancer, has been suggested to be synthetically lethal with depletion of RAD52. Pharmacologically inhibiting RAD52 specifically eradicates BRCA-deficient cancer cells. In this study, we demonstrated that curcumin, a plant...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Wei-Che, Chen, Chi-Yuan, Chern, Ching-Yuh, Wang, Chu-An, Lee, Wen-Chih, Chi, Ying-Chih, Cheng, Shu-Fang, Kuo, Yi-Tsen, Chiu, Ya-Chen, Tseng, Shih-Ting, Lin, Pei-Ya, Liou, Shou-Jhen, Li, Yi-Chen, Chen, Chin-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122931/
https://www.ncbi.nlm.nih.gov/pubmed/33922657
http://dx.doi.org/10.3390/ijms22094422

Ejemplares similares

Ejemplares similares